ERICA SHAFER: Open Payments
NPI 1619661881 · CANTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Boston Scientific Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: TRELEGY ELLIPTA, FANAPT, CAPLYTA, General - Pain Management, AIRSUPRA, JARDIANCE, OTEZLA, ZENPEP.
Industry payments across MI — which companies pay providers there.
